Rising survival rates for AML patients over 65 after allogeneic hematopoietic stem cell transplant

Among patients over 65 who received an allogeneic hematopoietic stem cell transplant (allo-HCT) for the treatment of acute myeloid leukemia (AML) between 2000 and 2021, leukemia-free and overall survival improved significantly over time.

Brain study unlocks secrets of strong drug memories

Researchers from the Medical Research Council Brain Network Dynamics Unit at the University of Oxford and the Nuffield Department of Clinical Neurosciences have identified a

January 24, 2024

Openwater Secures $100M to Tackle Diseases at the Cellular Level

What You Should Know: – Openwater, a pioneering healthcare technology company, today announced the acceleration of its plans to commercialize its groundbreaking platform that leverages

August 23, 2024

Propranolol helps control Parkinson’s tremors

The standard medication levodopa does not always work against tremors in Parkinson’s disease, especially in stressful situations.

December 23, 2024

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.